PNC Financial Services Group’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162K | Buy |
5,625
+2,230
| +66% | +$64.1K | ﹤0.01% | 2357 |
|
|
2025
Q1 | $114K | Buy |
3,395
+688
| +25% | +$23.1K | ﹤0.01% | 2576 |
|
|
2024
Q4 | $138K | Buy |
2,707
+187
| +7% | +$9.56K | ﹤0.01% | 2465 |
|
|
2024
Q3 | $129K | Buy |
2,520
+2,323
| +1,179% | +$119K | ﹤0.01% | 2513 |
|
|
2024
Q2 | $8.82K | Buy |
197
+80
| +68% | +$3.58K | ﹤0.01% | 3820 |
|
|
2024
Q1 | $5.48K | Buy |
117
+111
| +1,850% | +$5.2K | ﹤0.01% | 3933 |
|
|
2023
Q4 | $213 | Buy |
+6
| New | +$213 | ﹤0.01% | 4486 |
|